{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:11:46Z","timestamp":1777493506421,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Spanish Ministry of Economy and Competitiveness","award":["SAF2015-64948-C2-1-R"],"award-info":[{"award-number":["SAF2015-64948-C2-1-R"]}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["SAF2012-31035"],"award-info":[{"award-number":["SAF2012-31035"]}]},{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cient\u00edficas","doi-asserted-by":"publisher","award":["PIE-201580E109"],"award-info":[{"award-number":["PIE-201580E109"]}],"id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP11\/00165"],"award-info":[{"award-number":["CP11\/00165"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00372"],"award-info":[{"award-number":["PI14\/00372"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Commission - Marie Curie Actions FP7","award":["2012-CIG-322156"],"award-info":[{"award-number":["2012-CIG-322156"]}]},{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"crossref","award":["2015-03-1282"],"award-info":[{"award-number":["2015-03-1282"]}],"id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fundaci\u00f3n FIPSE","award":["12-00001344-15"],"award-info":[{"award-number":["12-00001344-15"]}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["SAF2015-63935"],"award-info":[{"award-number":["SAF2015-63935"]}]},{"name":"Spanish Ministry of Education"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ejmech.2017.02.034","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T15:46:46Z","timestamp":1487778406000},"page":"60-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Enzymatic and solid-phase synthesis of new donepezil-based L- and d-glutamic acid derivatives and their pharmacological evaluation in models related to Alzheimer's disease and cerebral ischemia"],"prefix":"10.1016","volume":"130","author":[{"given":"Leticia","family":"Monjas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana P.","family":"Arce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Egea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concepci\u00f3n","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Villarroya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela G.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6500-792X","authenticated-orcid":false,"given":"Mar\u00eda Isabel","family":"Rodr\u00edguez-Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.02.034_bib1","unstructured":"M. Prince, A. Wino, M. Guerchet, G.-C. Ali, Y.T. Wu, M. Prina, World Alzheimer Report 2015. The Global Impact of Dementia, Alzheimer\u2019s Disease International (ADI) Ed., London (http:\/\/www.worldalzreport2015.org\/)."},{"key":"10.1016\/j.ejmech.2017.02.034_bib2","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ejmech.2016.03.084","article-title":"Progress in drug development for Alzheimer's disease: an overview in relation to mitochondrial energy metabolism","volume":"121","author":"Hroudov\u00e1","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejmech.2013.09.050","article-title":"Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection","volume":"70","author":"Singh","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.arr.2014.03.008","article-title":"Alzheimer's disease, enzyme targets and drug discovery struggles: from natural products to drug prototypes","volume":"15","author":"Silva","year":"2014","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2017.02.034_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21091165","article-title":"Recent advances in neurogenic small molecules as innovative treatments for neurodegenerative diseases","volume":"21","author":"Herrera-Arozamena","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2017.02.034_bib6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JAD-122140","article-title":"A\u00a0meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease","volume":"35","author":"Di Santo","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2017.02.034_bib7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-132690","article-title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"41","author":"Tan","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2017.02.034_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cns.12484","article-title":"Role of donepezil in the management of neuropsychiatric symptoms in Alzheimer's disease and dementia with Lewy bodies","volume":"22","author":"Cummings","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejmech.2017.02.034_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2174\/156720512799015127","article-title":"Biochemical differentiation of cholinesterases from normal and Alzheimer's disease cortex","volume":"9","author":"Ciro","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2017.02.034_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/med.20248","article-title":"Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease","volume":"33","author":"Le\u00f3n","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2017.02.034_bib11","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/cmdc.201500418","article-title":"Aminobenzimidazoles and structural isomers as templates for dual-acting butyrylcholinesterase inhibitors and hCB2 R ligands to combat neurodegenerative disorders","volume":"11","author":"Dolles","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2017.02.034_bib12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/WNR.0b013e3283207d21","article-title":"Effects of cholinesterase inhibition on brain white matter volume in Alzheimer's disease","volume":"20","author":"Venneri","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejmech.2017.02.034_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3233\/JAD-160364","article-title":"Cerebral white matter changes on therapeutic response to rivastigmine in Alzheimer's disease","volume":"54","author":"Ho","year":"2016","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2017.02.034_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/1567205012666150325182702","article-title":"Oxidant\/antioxidant imbalance and the risk of Alzheimer's disease","volume":"12","author":"Moneim","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2017.02.034_bib15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2174\/1567205013666151221145445","article-title":"Evidence for mitochondrial UPR gene activation in familial and Sporadic Alzheimer's disease","volume":"13","author":"Beck","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2017.02.034_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/NEN.0b013e3181cb5af4","article-title":"Oxidative stress in the progression of Alzheimer disease in the frontal cortex","volume":"69","author":"Ansari","year":"2010","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejmech.2017.02.034_bib17","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.bbadis.2015.03.015","article-title":"Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer's disease","volume":"1852","author":"Mota","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2017.02.034_bib18","doi-asserted-by":"crossref","first-page":"408927","DOI":"10.1155\/2015\/408927","article-title":"Mitochondria-targeted protective compounds in Parkinson's and Alzheimer's diseases","volume":"2015","author":"Fern\u00e1ndez-Moriano","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2017.02.034_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.phrs.2015.05.007","article-title":"Mitochondrial Ca(2+) in neurodegenerative disorders","volume":"99","author":"Abeti","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2017.02.034_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.semcdb.2015.03.010","article-title":"Disturbed calcium signaling in spinocerebellar ataxias and Alzheimer's disease","volume":"40","author":"Egorova","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2017.02.034_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/0929867321666141106122628","article-title":"Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease","volume":"22","author":"Guzior","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/molecules21040466","article-title":"Navigating the chemical space of multitarget-directed ligands: from hybrids to fragments in Alzheimer's disease","volume":"21","author":"Prati","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2017.02.034_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4155\/fmc-2016-0003","article-title":"Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics","volume":"8","author":"Rosini","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib24","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1021\/acs.jmedchem.5b00624","article-title":"Novel levetiracetam derivatives that are effective against the Alzheimer-like phenotype in mice: synthesis, in\u00a0vitro, ex\u00a0vivo, and in\u00a0vivo efficacy studies","volume":"58","author":"Sola","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib25","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejmech.2016.07.052","article-title":"Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"123","author":"Wang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib26","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ejmech.2015.10.001","article-title":"Donepezil-like multifunctional agents: design, synthesis, molecular modeling and biological evaluation","volume":"121","author":"Wu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejmech.2016.05.055","article-title":"New cinnamic - N-benzylpiperidine and cinnamic - N,N-dibenzyl(N-methyl)amine hybrids as Alzheimer-directed multitarget drugs with antioxidant, cholinergic, neuroprotective and neurogenic properties","volume":"121","author":"Estrada","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib28","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4155\/fmc-2016-0036","article-title":"New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with sigma-1 agonism and beta-secretase inhibition","volume":"8","author":"Estrada","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib29","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1021\/acs.jmedchem.5b00245","article-title":"Novel N-acetyl bioisosteres of melatonin: melatonergic receptor pharmacology, physicochemical studies, and phenotypic assessment of their neurogenic potential","volume":"58","author":"de la Fuente Revenga","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib30","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/acschemneuro.5b00041","article-title":"Neurogenic potential assessment and pharmacological characterization of 6-methoxy-1,2,3,4-tetrahydro-beta-carboline (pinoline) and melatonin-pinoline hybrids","volume":"6","author":"de la Fuente Revenga","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2017.02.034_bib31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejmech.2014.04.075","article-title":"Dibenzo[1,4,5]thiadiazepine: a hardly-known heterocyclic system with neuroprotective properties of potential usefulness in the treatment of neurodegenerative diseases","volume":"81","author":"Gonz\u00e1lez-Mu\u00f1oz","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib32","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1021\/jm5000613","article-title":"New melatonin-N,N-dibenzyl(N-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease","volume":"57","author":"L\u00f3pez-Iglesias","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib33","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1021\/jm201460y","article-title":"New tacrine\u20134-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and beta-amyloid-reducing properties","volume":"55","author":"Fern\u00e1ndez-Bachiller","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib34","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1021\/jm900628z","article-title":"Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease","volume":"52","author":"Arce","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib35","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ceca.2011.06.006","article-title":"Multi-target novel neuroprotective compound ITH33\/IQM9.21 inhibits calcium entry, calcium signals and exocytosis","volume":"50","author":"Maroto","year":"2011","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ejmech.2017.02.034_bib36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.neuropharm.2012.12.001","article-title":"Novel multitarget ligand ITH33\/IQM9.21 provides neuroprotection in in\u00a0vitro and in\u00a0vivo models related to brain ischemia","volume":"67","author":"Lorrio","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2017.02.034_bib37","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12640-016-9623-7","article-title":"Neuroprotective effect of the novel compound ITH33\/IQM9.21 against oxidative stress and Na+ and Ca2+ overload in motor neuron-like NSC-34 cells","volume":"30","author":"Moreno-Ortega","year":"2016","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejmech.2017.02.034_bib38","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0957-4166(00)00210-X","article-title":"Regioselective lipase-catalysed \u03b3-monoamidation of D-glutamic acid diesters: effect of the N-protecting group","volume":"11","author":"Conde","year":"2000","journal-title":"Tetrahedron Asymmetry"},{"key":"10.1016\/j.ejmech.2017.02.034_bib39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A\u00a0new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.02.034_bib40","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib41","doi-asserted-by":"crossref","first-page":"8516","DOI":"10.1074\/jbc.M210432200","article-title":"Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production","volume":"278","author":"Li","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1023\/A:1005621125812","article-title":"The oligomycin axis of mitochondrial ATP synthase: OSCP and the proton channel","volume":"32","author":"Devenish","year":"2000","journal-title":"J.\u00a0Bioenerg. Biomembr."},{"key":"10.1016\/j.ejmech.2017.02.034_bib43","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/cn500131t","article-title":"ITH12410\/SC058: a new neuroprotective compound with potential in the treatment of Alzheimer's disease","volume":"5","author":"Romero","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2017.02.034_bib44","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.neuroscience.2006.12.036","article-title":"Neuroprotection afforded by nicotine against oxygen and glucose deprivation in hippocampal slices is lost in alpha7 nicotinic receptor knockout mice","volume":"145","author":"Egea","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2017.02.034_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-4580(93)90015-4","article-title":"The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system","volume":"14","author":"De Lacoste","year":"1993","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejmech.2017.02.034_bib46","doi-asserted-by":"crossref","first-page":"956792","DOI":"10.1155\/2013\/956792","article-title":"Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants","volume":"2013","author":"Poljsak","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2017.02.034_bib47","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ceca.2009.12.014","article-title":"The dysregulation of intracellular calcium in Alzheimer disease","volume":"47","author":"Supnet","year":"2010","journal-title":"Cell Calcium"},{"key":"10.1016\/j.ejmech.2017.02.034_bib49","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1471-4159.2007.04665.x","article-title":"Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress","volume":"102","author":"Egea","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib50","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2174\/1568007054546108","article-title":"Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair","volume":"4","author":"Noraberg","year":"2005","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.ejmech.2017.02.034_bib51","first-page":"11745","article-title":"Regioselective lipase-catalyzed synthesis of L-glutamic \u03b1-monoamide derivatives","volume":"53","author":"Conde","year":"1997","journal-title":"Eff. N-blocking group, Tetrahedron"},{"key":"10.1016\/j.ejmech.2017.02.034_bib52","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0968-0896(00)00020-1","article-title":"Lipase-catalysed synthesis of new acetylcholinesterase inhibitors: N-benzylpiperidine aminoacid derivatives","volume":"8","author":"Mart\u00ednez","year":"2000","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.02.034_bib53","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"89","author":"Denizot","year":"1986","journal-title":"J.\u00a0Immunol. Methods"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417300995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417300995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T19:28:47Z","timestamp":1656271727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417300995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":53,"alternative-id":["S0223523417300995"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.02.034","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enzymatic and solid-phase synthesis of new donepezil-based L- and d-glutamic acid derivatives and their pharmacological evaluation in models related to Alzheimer's disease and cerebral ischemia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.02.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}